Testing effectiveness (Phase 2)Ended earlyNCT00057447What this trial is testingSafety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma PatientsWho this might be right forNon-Hodgkin's Lymphoma InterMune 24
Large-scale testing (Phase 3)Ended earlyNCT00014326What this trial is testingInvolved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's LymphomaWho this might be right forLymphoma European Organisation for Research and Treatment of Cancer - EORTC 204
Large-scale testing (Phase 3)Study completedNCT00004031What this trial is testingSWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma SWOG Cancer Research Network 397
Early research (Phase 1)Ended earlyNCT03320642What this trial is testingGRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host DiseaseWho this might be right forHematologic Malignancies Incyte Corporation 84
Large-scale testing (Phase 3)Study completedNCT01987505What this trial is testingMabRella Study: A Study to Evaluate the Safety of Switching From Intravenous to Subcutaneous Administration of Rituximab During First-Line Treatment for LymphomaWho this might be right forLymphoma, Non Hodgkin Hoffmann-La Roche 140
Early research (Phase 1)Active Not RecruitingNCT06667687What this trial is testingStudy to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's LymphomaWho this might be right forNon-Hodgkin's Lymphoma AbbVie 21
Testing effectiveness (Phase 2)Study completedNCT00003402What this trial is testingPeripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaWho this might be right forLeukemiaLymphoma University of Maryland, Baltimore 35
Testing effectiveness (Phase 2)Study completedNCT00003039What this trial is testingFlavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell LymphomaWho this might be right forLymphoma National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)Ended earlyNCT02793583What this trial is testingStudy to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins LymphomaWho this might be right forDiffuse Large B-Cell LymphomaFollicular LymphomaMarginal Zone Lymphoma+2 more TG Therapeutics, Inc. 710
Testing effectiveness (Phase 2)Study completedNCT00842114What this trial is testingRituximab and CVP Plus Interferon for Follicular Non Hodgkins Lymphoma (NHL)Who this might be right forNon-Hodgkin's Lymphoma Fundación Leucemia y Linfoma, Spain 50
Early research (Phase 1)Study completedNCT00004101What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkin's LymphomaWho this might be right forLymphoma National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)WithdrawnNCT00003605What this trial is testingRituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's LymphomaWho this might be right forLymphoma Hoag Memorial Hospital Presbyterian
Testing effectiveness (Phase 2)Study completedNCT00006125What this trial is testingCombination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's LymphomaWho this might be right forLymphoma Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)Study completedNCT00073918What this trial is testingIodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forAnaplastic Large Cell LymphomaCutaneous B-cell Non-Hodgkin LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+14 more Fred Hutchinson Cancer Center 111
Early research (Phase 1)Study completedNCT00392691What this trial is testingMelphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous TreatmentWho this might be right forLymphoma Swiss Cancer Institute 20
Large-scale testing (Phase 3)UnknownNCT00003338What this trial is testingMonoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's LymphomaWho this might be right forLymphoma Gilead Sciences 60
Testing effectiveness (Phase 2)Study completedNCT00004171What this trial is testingPeripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's LymphomaWho this might be right forLymphoma Northwestern University
Large-scale testing (Phase 3)Study completedNCT00185393What this trial is testingTreatment With [90]Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma (Stage III or IV) Having Achieved a Partial or Complete Remission After First Line ChemotherapyWho this might be right forLymphoma, Non-Hodgkin Bayer 414
Testing effectiveness (Phase 2)UnknownNCT00036426What this trial is testingIdiotype Vaccine for Low-Grade Non-Hodgkin's LymphomaWho this might be right forLymphoma, Low-Grade Favrille 22
Early research (Phase 1)Study completedNCT00794638What this trial is testingA Phase I Clinical Trial of SyB L-0501 in Combination With Rituximab to Patients With Aggressive B-cell Non-Hodgkin's LymphomaWho this might be right forNon-Hodgkin's LymphomaDiffuse Large B-Cell LymphomaMantle Cell Lymphoma+1 more SymBio Pharmaceuticals 9